Ebos Group Limited (EBO) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the eBoss Group Limited FY25 four-year results conference call. At this time, all participants are in listen-only mode. There will be a presentation followed by a question and answer session, at which time if you wish to ask a question, you will need to press star 11 on your telephone keypad. You can cancel your request by pressing star 11 again. I must advise you that this conference is being recorded today, the 27th of August, 2025. I would now like to hand the conference over to your speaker today, Mr. Adam Hall, CEO, eBoss Group. Please go ahead, Adam. Good morning, everyone. Thank you for joining us for the eBoss Group's FY25 results presentation. I'm Adam Hall, the Chief Executive Officer of eBoss Group, and I'm joined today by Alastair Gray, our Chief Financial Officer, and Martin Krapskoff, our Chief Strategy and Corporate Development Officer. I'd like to say it's an honor to lead the eBoss team, and I've taken the opportunity to get to visit many of our businesses in Australia, New Zealand, and Southeast Asia since joining last month. I'm excited for how eBoss's capabilities are well suited for the opportunities ahead. Turning to the results, FY25 was another solid year for eBoss, reflecting the quality, scale, and leadership positions we hold across the various businesses within the portfolio. We delivered solid organic growth, which was supported by new customer wins in pharmacy wholesale, where we added over 320 stores nationally, particularly across both New South Wales and Victoria. Continued expansion of our pharmacy store network with 34 net new TWC stores added. We also expanded our medical technology business, including adding the Pacific Surgical Team in the Philippines. We also saw steady performance from o...